# Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized Cardiac Patients

> **NCT03647891** · NA · SUSPENDED · sponsor: **Kaiser Permanente** · enrollment: 150 (estimated)

## Conditions studied

- OSA
- Heart Failure
- Myocardial Infarction
- Arrhythmia, Cardiac

## Interventions

- **DEVICE:** Continuous Positive Airway Pressure

## Key facts

- **NCT ID:** NCT03647891
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-07
- **Primary completion:** 2024-09
- **Final completion:** 2025-04
- **Target enrollment:** 150 (ESTIMATED)
- **Why stopped:** Study on hold
- **Last updated:** 2022-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03647891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03647891, "Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized Cardiac Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03647891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*